Blue Owl Co-CEOs Remove Share Loans to Ease Stock Pressure
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
Already have an account? Sign in.
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
Abivax shares fell after Scorpion Capital claimed its ulcerative colitis drug is toxic. The company rejected the report and reaffirmed its Phase 3 data.
CrowdStrike is reportedly in talks to acquire Zscaler in a potential $265 billion cybersecurity deal, one of the largest in the sector.
Canadian Solar shares fell sharply after a report that the solar firm and its Recurrent Energy unit are considering asset sales and a possible Chapter 11 filing.
Be the first to know when deals break, stocks move, or biotech headlines hit.